Log in

NEWS


If you have any news to share with the public via the CINP's website or social media, please email info@cinp.org.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • March 01, 2025 01:20 | Anonymous
    For the March round of Editor's Picks, IJNP Editor-in-Chief Tony Grace, selects the following articles: 
    • Yingliang Dai et al.: Towards an expanded neurocognitive account of ketamine’s rapid antidepressant effects. Read HERE

    • Mustafa Tuncturk et al.: The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention. Read HERE

    • Rongzhen Sun et al.: Inhibition of PDE4B ameliorates cognitive defects in the model of alcoholic dementia in 3×Tg-AD mice via PDE4B/cAMP/PKA signaling. Read HERE


  • February 12, 2025 23:19 | Anonymous

    We are delighted to announce that the abstracts from the CINP2024 Congress in Tokyo have been published as a Supplement to the International Journal of Neuropsychopharmacology. 

    The Tokyo congress received a record number of abstract submissions of excellent quality and we are thrilled to be able to share these with the global audience now. 

    Read Here




  • February 01, 2025 23:09 | Anonymous
    For the February round of Editor's Picks, IJNP Editor-in-Chief Tony Grace, selects the following articles: 
    • Michael J. Mueller et al.: Pharmacokinetics and Pharmacodynamics of an Innovative Psychedelic N,N-Dimethyltryptamine/Harmine Formulation in Healthy Participants: A Randomized Controlled Trial. Read HERE

    • Haiting Zhao et al.: Disrupting heroin-associated memory reconsolidation through actin polymerization inhibition in the nucleus accumbens core. Read HERE


  • December 11, 2024 11:17 | Anonymous
    For the December & January round of Editor's Picks, IJNP Editor-in-Chief Tony Grace, selects the following articles: 
    • Alessandro Seretti et al.: Anhedonia is associated with a specific depression profile and poor antidepressant response. Read HERE

    • Helen M. Collins: Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms. Read HERE

    • Wei Guan et al.: A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARγ receptors. Read HERE


  • November 11, 2024 15:43 | Anonymous
    Pioneer Award

    We are delighted to announce the recipients of the CINP Pioneer Award in 2025.

    Prof. Siegfried Kasper (Austria)

    Prof. Brian Dean (Australia)

    The awards will be presented during the Opening ceremony of the CINP-AsCNP 2025 Joint Congress in Melbourne on June 15, 2025. 


  • November 05, 2024 13:37 | Anonymous
    For this round of Editor's Picks, IJNP Editor-in-Chief Tony Grace, selects the following articles: 
    • Randall L Morrison et al.: Effect of Esketamine Nasal Spray on Cognition in Patients with Treatment-Resistant Depression: Results from Four Phase-3 Studies. Read HERE

    • Zhang, Fang-fang et al.: Upregulation of Phosphodiesterase 7A Contributes to Concurrent Pain and Depression via Inhibition of cAMP-PKA-CREB-BDNF Signaling and Neuroinflammation in the Hippocampus of Mice. Read HERE

    • Katharina Domschke et al.: Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response? Read HERE


  • October 25, 2024 10:00 | Anonymous

    CINP President, Kazutaka Ikeda, visited the Philippines from September 24 to 27, delivering two lectures and engaging with leaders in the Philippine neuropsychopharmacology community.

    We are delighted that our Philippine colleagues agreed to organize two sessions for the CINP-AsCNP 2025 congress in Melbourne in June 2025. 

    This visit underscores CINP's commitment to fostering global collaboration and strengthening ties with national scientific societies.

    Read the full report HERE


  • October 18, 2024 10:00 | Anonymous

    As part of our mission ‘advancing worldwide neuroscience and education for brain and mental health’, CINP is committed to bringing opportunities for networking and education to all members of our global community.

    One of the most important ways in which we can achieve this is by rotating the World Congress to allow scientists and clinicians from all over the world to attend this prestigious event in person and we believe that our members have an important role to play in this process.

    We are therefore now seeking applications from CINP members to host CINP2027 – the 38th World Congress of Neuropsychopharmacology.

    Read more



  • October 16, 2024 10:00 | Anonymous

    We are delighted to present the Editor’s Picks - a new regular series of featured articles from the International Journal of Neuropsychopharmacology.

    This time, IJNP Editor-in-Chief Tony Grace, selects the following articles: 
    • Weiss, Emily R.: Metabotropic glutamatergic receptor 5 as a potential biomarker of the intersection of trauma and cannabis use. Read HERE

    • Nicholas E Bulthuis: GluN2B on Adult-Born Granule Cells Modulates (R,S)-Ketamine’s Rapid-Acting Effects in Mice. Read HERE

    • Gang Wang: GluN2A: A Promising Target for Developing Novel Antidepressants. Read HERE



  • August 20, 2024 20:29 | Anonymous

    Watch the recent CINP Webinars online: 

    Prof. Geraldine Dawson:

    Digital Health Approaches to the Early Detection of Autism

    Watch here

    Prof. Joseph Zohar: 

    Precision in Psychopharmacology: Is There Room for Neuroscience-based Nomenclature (NbN) in Clinical Practice?

    Watch here

    Prof. Stefano Pallanti: 
    TMS: Basic Principles, Clinical Uses, and Research Principles

    Watch here


<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

©2024 CINP